Los Angeles Injury Attorney Blog

On September 16, 2011, the U.S. Food and Drug Administration (FDA) announced a massive birth control recall due to a packaging error that may leave women at risk for an unplanned pregnancy. More than 1.4 million packs of affected birth control pills, manufactured by Qaulitest Pharmaceuticals, have been distributed to women over the last year and include Cyclafem 7/7/7, Emoquette and Previfem. The FDA is advising women to reference the lot number located at the bottom of the box or blister pack with the lot numbers listed here. Women taking one of the affected pills should immediately being using a non-hormonal form of birth control. Currently, the faulty packaging poses no immediate health risks. Consumers who have had an adverse reaction or quality issue with one of the affected products should contact Qualitest toll free at (877) 300-6153 or contact the FDA online.

Qualitest Pharmaceuticals, a subsidiary of Endo Pharmaceuticals, is currently investigating the source of the packaging error. Large pharmaceutical companies like Qualitest have a responsibility to provide consumers with products that work as advertised. If the manufacturer produces a defective product, the manufacturer may be liable for damages associated with the use of their product. Women who have suffered an unintended pregnancy as a result of taking a defective birth control pill may be able to recover funds for pregnancy-related damages.

Defective Product Lawyers

At Estey Bomberger, our Los Angeles defective product lawyers represent the individual and not big business. We will use every available resource to make sure large corporations are held accountable. To learn how we can assist you with the legal process, call our law firm today. It costs nothing to speak with one of our lawyers and if we take your case, there is no fee until we get you compensation.

Continue reading "More than 1.4 Million Packages of Birth Control Are Recalled Due to Packaging Error" »

In product liability news, earlier this month a federal jury in New Hampshire awarded $21 million to a woman who suffered severe burn injuries and blindness after taken the anti-inflammatory medication Clinoril (sulindac) for shoulder pain. The jury found, after deliberating for three days, that the manufacturer of Clinoril, Mutual Pharmaceutical Co., should have known the dangers of the drug. According to the plaintiff's attorneys, the jury's verdict was the largest award in a New Hampshire product liability lawsuit.

The plaintiff, Karen Bartlett, 51, spent 112 days in five hospitals, including the burn unit at Massachusetts General Hospital. She was diagnosed with Stevens-Johnson Syndrome and toxic epidermal necrolysis. She is legally blind, despite having undergone 12 eye operations. Mutual Pharmaceutical argued that the drug has been approved by the FDA for 32 years. The judge presiding over the case instructed jurors that in order for them to hold Mutual liable, they had to find the drug unreasonably dangerous and the underlying cause of Bartlett's condition.

Continue reading "Jury Awards $21 Million to Woman Blinded by Anti-Inflammatory Drug " »